Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hyperpolarized Xenon-129 MRI vs Xenon-133 Scintigraphy in COPD
NCT03331302Phase 2Recruiting
- Sponsor
- University of Virginia
- Start
- Sep 2018
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hyperpolarized xenon gas in chronic obstructive pulmonary disease (COPD), sponsored by University of Virginia. Started Sep 2018; status: recruiting.
02
Drugs
hyperpolarized xenon gas
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03331302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331302.